PapersPMID:34578932
Effect of Spirulina Supplementation on Systolic and Diastolic Blood Pressure: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- meta-analysis
- Dose studied, every finding
- 1 to 8 g per day
What moved
How to read these marks →“Pooled analysis revealed that Spirulina intake led to a significant lowering of SBP (MD: −4.59 mmHg, 95% CI: −8.20 to −0.99, I2 = 65%).”
- Effect
- −4.59 mean difference, 95% CI −8.2 to −0.99
- Population
- Adults with co-existing disease (hypertension, type 2 diabetes, chronic joint pain, ulcerative colitis) in 5 parallel-group randomised trials of spirulina; four used placebo and one no intervention as control
- Decreases diastolic blood pressure
moderatereplicated ×2
“Pooled analysis of 4 RCTs showed that Spirulina intake significantly lowered DBP (MD: −4.29 mmHg, CI: −8.43 to −0.14, I2 = 81%) in comparison with the control group.”
- Effect
- −4.29 mean difference, 95% CI −8.43 to −0.14
- Population
- Adults with co-existing disease in 4 randomised trials of spirulina with diastolic data; all-trials pool before the sensitivity exclusion
Study record
- Design
- meta-analysis
- Species
- human
- Population
- Adults in 5 parallel-group RCTs of Spirulina, with hypertension, type 2 diabetes mellitus, chronic joint pain or ulcerative colitis
- Participants
- 230
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 9